Filler pricing is not a commodity game. While Juvéderm and Restylane dominate shelf space, your margin per syringe depends on acquisition cost, loyalty rebates, patient demand by area, and whether you're pricing to volume or value. A practice owner needs to understand the real cost structure—what you actually pay after rebates, how crosslinking and rheology drive clinical outcomes (and thus pricing power), and how to calculate margin per treatment area rather than per syringe. This guide walks through the economics of the major HA fillers and biostimulators, the loyalty programs that move the needle, and how to think strategically about your product mix.